First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells | |
Wu J(吴骏); Hu Zhongjie; Wang L(王柳); Tan YQ(谭元卿); Hou Wei; Li ZW(李仲文); Gao TT(高婷婷); Fan JQ(范佳琪); Guo BJ(郭保杰); Dai Huaping | |
刊名 | CELL PROLIFERATION |
2020 | |
卷号 | 53期号:12页码:e12943 |
内容类型 | 期刊论文 |
源URL | [http://ir.ioz.ac.cn/handle/000000/14489] |
专题 | 干细胞与生殖生物学国家重点实验室 |
推荐引用方式 GB/T 7714 | Wu J,Hu Zhongjie,Wang L,et al. First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells[J]. CELL PROLIFERATION,2020,53(12):e12943. |
APA | 吴骏.,Hu Zhongjie.,王柳.,谭元卿.,Hou Wei.,...&胡宝洋.(2020).First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells.CELL PROLIFERATION,53(12),e12943. |
MLA | 吴骏,et al."First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells".CELL PROLIFERATION 53.12(2020):e12943. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论